Vericel Stock

Vericel FCF Margin

The Free Cash Flow Margin of Vericel (VCEL) as of Aug 16, 2026 is 8.96 %. In the previous year, Free Cash Flow Margin was -2.45 % — a change of -465.71% (higher).

FCF Margin

8.96 %

YoY

-465.71%

Last updated:

Free Cash Flow Margin of Vericel is 2026 8.96 % . Free Cash Flow Margin of Vericel was 2025 -2.45 % . It decreases by -465.71% higher compared to the previous year.
Access this data via the Eulerpool API

Vericel Stock analysis

What does Vericel do? Vericel Corp is a US biotechnology company specializing in the development and commercialization of innovative cell therapies for patients with serious diseases. The company is headquartered in Cambridge, Massachusetts and was founded in 1997. Vericel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vericel stock

Free Cash Flow Margin of Vericel is 8.96 % in 2026.

Free Cash Flow Margin of Vericel changed from -2.45 % to 8.96 %, representing a -465.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Vericel since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Vericel with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Vericel

All Key Metrics — Vericel